Loading…
NSE · Source: NSE
Sai Parenteral's Limited is a diversified pharmaceutical formulations company engaged in Branded Generic Formulations and CDMO products and services. The company operates five manufacturing facilities in India and has recently acquired a 74.60% stake in Noumed Pharmaceuticals Pty Limited.
The Indian pharmaceutical industry is projected to grow at a CAGR of 11.2%, reaching $146 billion by 2033. The CDMO market is also expected to grow significantly, driven by increasing demand for pharmaceutical products.